Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (177)

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses

Journal Article

Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas

Meeting Abstract

O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; more...
Annals of Oncology (2008)

Fulltext@MSK | Save

Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047

Meeting Abstract

Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
Blood (2008)

Fulltext@MSK | Save

Clofarabine is active in peripheral T-cell lymphomas: Results of the phase I portion of a phase I/II study

Meeting Abstract

Horwitz, S.; Mulford, D.; Paul, H.; Weissbrot, H.; Zelenetz, A. D.
Annals of Oncology (2008)

Fulltext@MSK | Save

Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity

Journal Article

Hoppe, B. S.; Moskowitz, C. H.; Filippa, D. A.; Moskowitz, C. S.; Kewalramani, T.; Zelenetz, A. D.; Yahalom, J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome, for patients with hepatosplenic T-Cell lymphoma: A single institution experience

Meeting Abstract

Voss, M.; Zelenetz, A.; Papadopoulos, E. B.; Weissbrot, H.; Horwitz, S. M.
Blood (2007)

Fulltext@MSK | Save

Vaccine efficacy following autologous peripheral blood stem cell transplant for lymphoma

Meeting Abstract

Small, T. N.; Rice, R. D.; Mccullagh, E.; Noy, A.; Trippett, T.; Horwitz, S. M.; Zelenetz, A. D.; Moskowitz, C.
Blood (2007)

Fulltext@MSK | Save

Late relapses characterize autologous transplantation (ASCT) in first complete remission (CR) for peripheral T-cell lymphoma (PTCL)

Meeting Abstract

Kewalramani, T.; Horwitz, S.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

Journal Article

O'Connor, O. A.; Hamlin, P. A.; Portlock, C.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Macgregor-Cortelli, B.; Neylon, E.; Sarasohn, D.; Dumetrescu, O.; more...
British Journal of Haematology (2007)

Fulltext@MSK | Save

Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporine

Journal Article

Advani, R.; Horwitz, S.; Zelenetz, A.; Horning, S. J.
Leukemia and Lymphoma (2007)

Fulltext@MSK | Save